Not yet recruiting NCT07521241
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: AD-230, AD-2301.
- Who it may be relevant to
- Registry conditions: Chronic Liver Disease (CLD). Basic parameters: 19 years — 64 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Randomized, Open-label, Two-treatment, Two-period, Two-sequence Crossover Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Overview
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Interventions
- Drug AD-230, AD-2301
Oral administration of AD-230 or AD-2301, according to randomized sequence.
Primary outcome measures
- AUClast [Time frame: -24hours to 72hours]
- Cmax [Time frame: -24hours to 72hours]
Eligibility criteria
Inclusion criteria
- \- Body mass index (BMI) between 18.5 kg/m2 and 29.9 kg/m2 at the time of screening visit
- Subjects aged 19 years or older and under 65 years at the screening visit
Exclusion criteria
- Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
- Other exclusions applied
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
South Korea · 1 center
- Kyungpook National university hospital — Seoul
Identifiers
NCT: NCT07521241 · AD-230BE